{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:36:18Z","timestamp":1793500578970,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU112-MF-17"],"award-info":[{"award-number":["CMU112-MF-17"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2320-B-039-007-MY2"],"award-info":[{"award-number":["112-2320-B-039-007-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-039-065"],"award-info":[{"award-number":["NSTC 113-2314-B-039-065"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 111-2314-B-002-145"],"award-info":[{"award-number":["NSTC 111-2314-B-002-145"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trsl.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:09:04Z","timestamp":1776899344000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Repurposing eravacycline as an immunomodulator for immunodeficiencies driven by anti-IFN-\u03b3 autoantibodies"],"prefix":"10.1016","volume":"292","author":[{"given":"Yu-Ting","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ju","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Tang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Tung","family":"Kiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Sing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Un-In","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.04.006_bib0001","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-gamma autoantibodies underlie disseminated Talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.04.006_bib0002","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2147\/IDR.S312042","article-title":"Talaromyces marneffei and Burkholderia cepacia Co-infection in a HIV-uninfected patient with anti-interferon-gamma autoantibodies","volume":"14","author":"Zeng","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.trsl.2026.04.006_bib0003","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.cmi.2020.02.030","article-title":"Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies","volume":"26","author":"Wu","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.trsl.2026.04.006_bib0004","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.04.006_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-gamma autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trsl.2026.04.006_bib0006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-gamma autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2026.04.006_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1051673","article-title":"Pathogen spectrum and immunotherapy in patients with anti-IFN-gamma autoantibodies: a multicenter retrospective study and systematic review","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.04.006_bib0008","article-title":"A potential link between environmental triggers and autoimmunity","volume":"2014","author":"Vojdani","year":"2014","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.trsl.2026.04.006_bib0009","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of interferon-gamma neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2018","journal-title":"Clin Infect Dis : An Official Pub Infect Dis Society Am"},{"key":"10.1016\/j.trsl.2026.04.006_bib0010","article-title":"Natural history and evolution of anti-interferon-gamma autoantibody-Associated Immunodeficiency Syndrome in Thailand and the US","author":"Hong","year":"2019","journal-title":"Clin Infect Dis : An Official Pub Infect Dis Society Am"},{"key":"10.1016\/j.trsl.2026.04.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-gamma autoantibodies","volume":"14","author":"Angkasekwinai","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2026.04.006_bib0012","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nature Medicine"},{"key":"10.1016\/j.trsl.2026.04.006_bib0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1208\/s12248-012-9322-0","article-title":"Structure-based virtual screening for drug discovery: a problem-centric review","volume":"14","author":"Cheng","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.trsl.2026.04.006_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.trsl.2026.04.006_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645485","article-title":"Repurposing immunomodulatory drugs to combat tuberculosis","volume":"12","author":"Fatima","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.04.006_bib0016","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1038\/s41598-022-11774-9","article-title":"Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency","volume":"12","author":"Yasamut","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2026.04.006_bib0017","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0969-2126(00)00184-2","article-title":"Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex","volume":"8","author":"Thiel","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.trsl.2026.04.006_bib0018","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/bts186","article-title":"Douguet D. e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design","volume":"28","author":"Pihan","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2026.04.006_bib0019","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41401-022-00996-2","article-title":"DrugRep: an automatic virtual screening server for drug repurposing","volume":"44","author":"Gan","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2026.04.006_bib0020","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2026.04.006_bib0021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.trsl.2026.04.006_bib0022","doi-asserted-by":"crossref","first-page":"ofz484","DOI":"10.1093\/ofid\/ofz484","article-title":"Patients with idiopathic pulmonary nontuberculous mycobacterial disease have normal Th1\/Th2 cytokine responses but diminished Th17 cytokine and enhanced granulocyte-macrophage colony-stimulating factor production","volume":"6","author":"Wu","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.trsl.2026.04.006_bib0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0969-2126(01)00567-6","article-title":"The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex","volume":"9","author":"Randal","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.trsl.2026.04.006_bib0024","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/376230a0","article-title":"Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor","volume":"376","author":"Walter","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.04.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212126","article-title":"Pathogenic autoantibodies to IFN-gamma act through the impedance of receptor assembly and Fc-mediated response","volume":"219","author":"Shih","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.04.006_bib0026","doi-asserted-by":"crossref","first-page":"253S","DOI":"10.1592\/phco.21.16.253S.33993","article-title":"Fluoroquinolone adverse effects and drug interactions","volume":"21","author":"Fish","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.trsl.2026.04.006_bib0027","article-title":"In vitro susceptibility testing of eravacycline against nontuberculous mycobacteria","volume":"66","author":"Brown-Elliott","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.trsl.2026.04.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178263","article-title":"Neutralizing IFN-gamma autoantibodies are rare and pathogenic in HLA-DRB1\u00d715:02 or 16:02 individuals","volume":"134","author":"Peel","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.04.006_bib0029","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41590-023-01420-5","article-title":"IFNgamma binding to extracellular matrix prevents fatal systemic toxicity","volume":"24","author":"Kemna","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.04.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102860","article-title":"Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus","volume":"131","author":"Ning","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2026.04.006_bib0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2026.04.006_bib0032","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1111\/bph.14494","article-title":"Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution","volume":"175","author":"Garrido-Mesa","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2026.04.006_bib0033","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s10875-023-01537-0","article-title":"Characteristics and outcomes of anti-interferon gamma antibody-associated adult onset immunodeficiency","volume":"43","author":"Zhang","year":"2023","journal-title":"J Clin Immunol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:26:34Z","timestamp":1783185994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S1931524426000861"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.04.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing eravacycline as an immunomodulator for immunodeficiencies driven by anti-IFN-\u03b3 autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}